Severe, critical, or fatal COVID-19

1. Statins raise the risk of severe, critical, or fatal COVID-19 in humans (ARD 0.62, 95% CI 0.34-0.90).

   HumansCOVID-19 excluding individuals with prevalent CVD

   Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019

   IJID regions·10 Jul 2026

2. Statins lower the risk of severe, critical, or fatal COVID-19 in humans (ARD -0.79, 95% CI -1.10 to -0.48).

   HumansCOVID-19 in individuals aged >60 years

   Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019

   IJID regions·10 Jul 2026

More on Statins